<DOC>
	<DOCNO>NCT01476007</DOCNO>
	<brief_summary>Objective : To determine effectiveness oral versus intramuscular Cobalamin ( vitamin B12 ) restore cobalamin parameter blood 8 , 26 52 week ≥ 65 age patient Cobalamin Deficiency . Design : Noninferiority randomise control trial , pragmatic multi-center primary healthcare set ( Madrid Region ) . Participants : ≥ 65 age patient Cobalamin Deficiency . Patients give inform consent . Number patient : 320 ( 160 arm ) . Assignment : randomize simple ( automatic system ) . Variables . Main outcome variable : Cobalamin level standardization ( yes/no ) . Secondary outcome variable : Adverse event . Adherence measurement treatment . Health related quality life questionnaire ( Euroqol-5D ) . Satisfaction preference . Other variable : Gender . Age . Live alone . Vegetarian diet . Alcohols consume . Clinic Variables ( symptoms physical examination ) blood parameter . Drugs consume . Causes loss withdrawal . Number patient ( age gender ) decline participate . All data ( exclude patient identification data ) record electronic database . Intervention group : oral Optovite® B12 1000 gamma . Control group : idem intramuscular . Analysis : Descriptive analysis ( screen phase ) . Baseline comparison two intervention group . Effect cobalamin ( main outcome variable ) . Security . Quality life . Adherence measurement treatment .</brief_summary>
	<brief_title>Oral/Intramuscular B12 Treat Cobalamin Deficiency</brief_title>
	<detailed_description>Variables . Main outcome variable : Cobalamin level standardization ( yes/no ) . Secondary outcome variable : Adverse event . Adherence measurement treatment . Health related quality life questionnaire ( Euroqol-5D ) . Satisfaction preference . Other variable : Gender . Age . Live alone . Vegetarian diet . Alcohols consume . Clinic Variables ( symptoms physical examination ) blood parameter . Drugs consume . Causes loss withdrawal . Number patient ( age gender ) decline participate . All data ( exclude patient identification data ) record electronic database . Intervention group : oral Optovite® B12 1000 gamma . Control group : idem intramuscular . Analysis : Descriptive analysis ( screen phase ) . Baseline comparison two intervention group . Effect cobalamin ( main outcome variable ) . Security . Quality life . Adherence measurement treatment .</detailed_description>
	<mesh_term>Vitamin B 12 Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>≥ 65 age patient Cobalamin Deficiency . Patients give inform consent . Treatment B12 ( 1 last year ) Neurologic psychiatric pathology Folic acid &lt; 2.3ng/ml ...</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>primary health care</keyword>
	<keyword>Vitamin B 12 Deficiency</keyword>
</DOC>